A synthetic analog of fibrinogen alpha 27-50 is an inhibitor of thrombin
- PMID: 2053103
A synthetic analog of fibrinogen alpha 27-50 is an inhibitor of thrombin
Abstract
Binding of the synthetic peptide AAKDSDWPFAS-DEDWNYKAPSGAR, a fibrinogen alpha 27-50 analog, to thrombin was studied by inhibition assays and affinity chromatography. Peptide alpha 27-50 corresponds to a segment of human fibrinogen downstream from the thrombin cleavage site, with cysteine residues at positions 28, 36, 45 and 49 replaced by alanine. The peptide inhibited clotting of fibrinogen with an inhibition constant of 190-400 microM. Cleavage of fibrinopeptides A and B was inhibited by the peptide and the peptide was competitive with fibrinogen for thrombin. Inhibition of the small substrate tosyl-Gly-Pro-Arg-p-nitroaniline was not observed indicating that the peptide did not block the active site of the enzyme. Peptide alpha 27-50 that was covalently linked to Sepharose bound active site-inhibited thrombin at low ionic strength and was eluted at higher salt concentration. The peptide was not cleaved on overnight exposure to thrombin as determined by reverse phase HPLC. In summary, the peptide bound to, but was not a substrate for thrombin. These results suggest that this region of fibrinogen contributes to binding of thrombin.
Similar articles
-
Release of fibrinopeptides by the slow and fast forms of thrombin.Biochemistry. 1996 Apr 9;35(14):4417-26. doi: 10.1021/bi952834d. Biochemistry. 1996. PMID: 8605191
-
Structural examination of the influence of phosphorylation on the binding of fibrinopeptide A to bovine thrombin.Biochemistry. 1998 Apr 28;37(17):5888-902. doi: 10.1021/bi972538w. Biochemistry. 1998. PMID: 9558322
-
Synthetic peptides and peptidomimetics as substrates and inhibitors of thrombin and other proteases in the blood coagulation system.Blood Coagul Fibrinolysis. 1994 Jun;5(3):411-36. Blood Coagul Fibrinolysis. 1994. PMID: 8075312 Review.
-
Radioimmunoassay of human fibrinopeptide B and kinetics of fibrinopeptide cleavage by different enzymes.J Clin Invest. 1975 Aug;56(2):438-45. doi: 10.1172/JCI108110. J Clin Invest. 1975. PMID: 50328 Free PMC article.
-
Thrombin active-site regions.Semin Thromb Hemost. 1986 Jul;12(3):200-8. doi: 10.1055/s-2007-1003551. Semin Thromb Hemost. 1986. PMID: 3535077 Review.
Cited by
-
Nanoscale probing reveals that reduced stiffness of clots from fibrinogen lacking 42 N-terminal Bbeta-chain residues is due to the formation of abnormal oligomers.Biophys J. 2009 Mar 18;96(6):2415-27. doi: 10.1016/j.bpj.2008.12.3913. Biophys J. 2009. PMID: 19289066 Free PMC article.
-
Characterization of the reciprocal binding sites on human alpha-thrombin and factor XIII A-chain.Mol Cell Biochem. 1998 Jan;178(1-2):289-97. doi: 10.1023/a:1006807312772. Mol Cell Biochem. 1998. PMID: 9546612